Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Eli Lilly and Company LLY
$434.97
+$0.55 (0.13%)
На 18:00, 12 мая 2023
-17.05%
Потенциал через год
Ранг: 1
Ключевые показатели
-
Marketcap
413171083696.00000000
-
week52high
445.54
-
week52low
283.11
-
Revenue
28541400000
-
P/E TTM
207
-
Beta
0.36297500
-
EPS
6.31000000
-
Last Dividend
4.52000000
-
Next Earnings Date
27 апр 2023 г. в 14:00
Описание компании
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various head and neck cancers; Retevmo for metastatic NSCLC, medullary thyroid cancer, and thyroid cancer; Tyvyt for relapsed or refractory classic Hodgkin's lymph and non-squamous NSCLC; and Verzenio for HR+, HER2- metastatic breast cancer, node positive, and early breast cancer. It offers Olumiant for rheumatoid arthritis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis. The company offers Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Emgality for migraine prevention and episodic cluster headache; and Zyprexa for schizophrenia, bipolar I disorder, and bipolar maintenance. Its Bamlanivimab and etesevimab, and Bebtelovimab for COVID-19; Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. The company has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; AbCellera Biologics Inc.; Junshi Biosciences; Regor Therapeutics Group; Lycia Therapeutics, Inc.; Kumquat Biosciences Inc.; Entos Pharmaceuticals Inc.; and Foghorn Therapeutics Inc. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Morgan Stanley | Overweight | Overweight | 08 июл 2022 г. |
| Barclays | Overweight | Overweight | 07 июл 2022 г. |
| JP Morgan | Overweight | Overweight | 01 июн 2022 г. |
| SVB Leerink | Outperform | 23 мая 2022 г. | |
| Mizuho | Buy | Buy | 02 мая 2022 г. |
| Morgan Stanley | Overweight | Overweight | 07 сент 2022 г. |
| BMO Capital | Outperform | Outperform | 06 сент 2022 г. |
| UBS | Buy | Neutral | 22 сент 2022 г. |
| Morgan Stanley | Overweight | Overweight | 12 окт 2022 г. |
| Wells Fargo | Equal-Weight | Equal-Weight | 02 ноя 2022 г. |
| SVB Leerink | Outperform | Outperform | 02 ноя 2022 г. |
| Morgan Stanley | Overweight | Overweight | 02 ноя 2022 г. |
| Barclays | Overweight | Overweight | 02 ноя 2022 г. |
| Goldman Sachs | Neutral | Neutral | 08 ноя 2022 г. |
| Berenberg | Buy | Buy | 22 ноя 2022 г. |
| Credit Suisse | Outperform | 18 ноя 2022 г. | |
| Morgan Stanley | Overweight | Overweight | 17 ноя 2022 г. |
| Wells Fargo | Equal-Weight | Equal-Weight | 08 дек 2022 г. |
| Guggenheim | Buy | Buy | 07 дек 2022 г. |
| Morgan Stanley | Overweight | Overweight | 06 дек 2022 г. |
| Credit Suisse | Outperform | Outperform | 06 дек 2022 г. |
| Cowen & Co. | Outperform | Outperform | 05 дек 2022 г. |
| Barclays | Overweight | Overweight | 03 янв 2023 г. |
| SVB Leerink | Outperform | Outperform | 16 дек 2022 г. |
| UBS | Buy | Buy | 15 дек 2022 г. |
| Morgan Stanley | Overweight | Overweight | 14 дек 2022 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Покожие компании
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| White Anne E. | D | 0 | 7264 | 01 февр 2023 г. |
| White Anne E. | D | 54364 | 3252 | 01 февр 2023 г. |
| White Anne E. | A | 57616 | 7264 | 01 февр 2023 г. |
| Skovronsky Daniel | D | 0 | 15675 | 01 февр 2023 г. |
| Skovronsky Daniel | D | 87199 | 7035 | 01 февр 2023 г. |
| Skovronsky Daniel | A | 94234 | 15675 | 01 февр 2023 г. |
| Pusey Leigh Ann | D | 0 | 3154 | 01 февр 2023 г. |
| Pusey Leigh Ann | D | 27960 | 1438 | 01 февр 2023 г. |
| Pusey Leigh Ann | A | 29398 | 3154 | 01 февр 2023 г. |
| Norton Johna | D | 0 | 2102 | 01 февр 2023 г. |
Institutional Ownership
Institutional Ownership
| Holder | Shares | Change | Date Reported |
|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 24248600 | -211590 | 31 авг 2020 г. |
| Vanguard 500 Index Fund | 17305100 | -62823 | 31 авг 2020 г. |
| SPDR S&P 500 ETF | 8857590 | -42081 | 31 авг 2020 г. |
| US Bank Vanguard Institutional 500 Index Trust | 7235960 | -33192 | 31 авг 2020 г. |
| iShares Core S&P 500 ETF | 6372130 | -34612 | 31 авг 2020 г. |
| Vanguard Value Index Fund | 5768530 | 75591 | 31 авг 2020 г. |
| Fidelity 500 Index Fund | 7501810 | -8118 | 31 июл 2020 г. |
| Fidelity Contrafund | 6327490 | 47402 | 31 июл 2020 г. |
| Vanguard PRIMECAP Fund | 21764200 | -725200 | 30 июн 2020 г. |
| Vanguard Health Care Fund | 10526500 | -2996450 | 30 июн 2020 г. |
Новостная лента
Eli Lilly on track to close with a higher market cap than J&J for first time since 1997
Market Watch
12 мая 2023 г. в 12:55
Eli Lilly & Co. was on track Friday to close with a greater market capitalization than Johnson & Johnson for the first time since October 1997, according to Dow Jones Market Data.
Here's What Eli Lilly's Latest Clinical Win Means For Investors
The Motley Fool
12 мая 2023 г. в 06:20
Eli Lilly's donanemab just proved effective in treating Alzheimer's disease in a pivotal clinical trial. This should be yet another key addition to Eli Lilly's expanding lineup.
Prescription-drug costs in spotlight as pharmacy benefit reform advances in Senate
Market Watch
11 мая 2023 г. в 14:46
A bipartisan effort to rein in prescription drug prices advanced Thursday as a key U.S. Senate committee approved a bill aimed at reforming pharmacy benefit managers.
Here's Why Eli Lilly's Alzheimer's Drug Could Be the Real Deal
The Motley Fool
11 мая 2023 г. в 10:07
Trial data show that donanemab may potentially slow the progression of Alzheimer's. The drug candidate has also been effective in reducing amyloid plaque in the brain.
Eli Lilly CEO vows not to raise insulin prices again, while Novo Nordisk and Sanofi hedge
CNBC
10 мая 2023 г. в 17:37
He was the only executive to do so before a Senate Health Committee hearing that also included the CEOs of Novo Nordisk and Sanofi.